Gallimore, J. R.

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A., Lachmann, H. J., Gallimore, J. R., Lovat, L. B., Bartfai, T., Alanine, A., Hertel, C., et al. (2002) · Nature

Amyloidosis: Diagnosis, Treatment, OutcomesAlzheimer's disease research and treatments

Cited by 540

Low‐level increases in serum C‐reactive protein are present in early osteoarthritis of the knee and predict progressive disease

Spector, T. D., Hart, D. J., Nandra, D., Doyle, D. V., Mackillop, N., Gallimore, J. R., & Pepys, M. B. (1997) · Arthritis & Rheumatism

Osteoarthritis Treatment and MechanismsRheumatoid Arthritis Research and Therapies

Cited by 403

Amyloid P component. A critical review

Pepys, M. B., Booth, D. R., Hutchinson, W. L., Gallimore, J. R., Collins, I. M., & Hohenester, E. (1997) · Amyloid

Biomarkers in Disease MechanismsComplement system in diseases

Cited by 181